Literature DB >> 17360743

The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.

Ian Bell1, Ashley Martin, Sally Roberts.   

Abstract

Human papillomavirus (HPV) infections of the squamous epithelium are associated with high-level expression of the E1circumflexE4 protein during the productive phase of infection. However, the precise mechanisms of how E1circumflexE4 contributes to the replication cycle of the virus are poorly understood. Here, we show that the serine-arginine (SR)-specific protein kinase SRPK1 is a novel binding partner of HPV type 1 (HPV1) E1circumflexE4. We map critical residues within an arginine-rich domain of HPV1 E1circumflexE4, and in a region known to facilitate E1circumflexE4 oligomerization, that are requisite for SRPK1 binding. In vitro kinase assays show that SRPK1 binding is associated with phosphorylation of an HPV1 E1circumflexE4 polypeptide and modulates autophosphorylation of the kinase. We show that SRPK1 is sequestered into E4 inclusion bodies in terminally differentiated cells within HPV1 warts and that colocalization between E1circumflexE4 and SRPK1 is not dependent on additional HPV1 factors. Moreover, we also identify SRPK1 binding of E1circumflexE4 proteins of HPV16 and HPV18. Our findings indicate that SRPK1 binding is a conserved function of E1circumflexE4 proteins of diverse virus types. SRPK1 influences important biochemical processes within the cell, including nuclear organization and RNA metabolism. While phosphorylation of HPV1 E4 by SRPK1 may directly influence HPV1 E4 function during the infectious cycle, the modulation and sequestration of SRPK1 by E1circumflexE4 may affect the ability of SRPK1 to phosphorylate its cellular targets, thereby facilitating the productive phase of the HPV replication cycle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360743      PMCID: PMC1900295          DOI: 10.1128/JVI.02609-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA.

Authors:  Y Huang; J A Steitz
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

2.  Modulation of the cell division cycle by human papillomavirus type 18 E4.

Authors:  Tomomi Nakahara; Akiko Nishimura; Masakazu Tanaka; Takaharu Ueno; Akinori Ishimoto; Hiroyuki Sakai
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 3.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

4.  The binding of lamin B receptor to chromatin is regulated by phosphorylation in the RS region.

Authors:  Makoto Takano; Masaki Takeuchi; Hiromi Ito; Kazuhiro Furukawa; Kenji Sugimoto; Saburo Omata; Tsuneyoshi Horigome
Journal:  Eur J Biochem       Date:  2002-02

5.  The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.

Authors:  Sally Roberts; Michele L Hillman; Gillian L Knight; Phillip H Gallimore
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Functional coexpression of serine protein kinase SRPK1 and its substrate ASF/SF2 in Escherichia coli.

Authors:  B G Yue; P Ajuh; G Akusjärvi; A I Lamond; J P Kreivi
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

7.  Functional inactivation of the SR family of splicing factors during a vaccinia virus infection.

Authors:  Tien-sheng Huang; Camilla Estmer Nilsson; Tanel Punga; Goran Akusjarvi
Journal:  EMBO Rep       Date:  2002-10-22       Impact factor: 8.807

8.  The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus.

Authors:  J Doorbar; R C Elston; S Napthine; K Raj; E Medcalf; D Jackson; N Coleman; H M Griffin; P Masterson; S Stacey; Y Mengistu; J Dunlop
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

9.  Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16.

Authors:  Clare E Davy; Deborah J Jackson; Qian Wang; Kenneth Raj; Phillip J Masterson; Nicola F Fenner; Shirley Southern; Scott Cuthill; Jonathan B A Millar; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more
  23 in total

1.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Programmable protein arrays for immunoprofiling HPV-associated cancers.

Authors:  Radwa Ewaisha; Ian Meshay; Jack Resnik; Benjamin A Katchman; Karen S Anderson
Journal:  Proteomics       Date:  2016-04-04       Impact factor: 3.984

4.  IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions.

Authors:  Maria Magdalena Koczorowska; Anna Kwasniewska; Anna Gozdzicka-Jozefiak
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

5.  Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif.

Authors:  Qingming Ding; Lili Li; Peter Whyte
Journal:  Mol Cell Biochem       Date:  2012-10-13       Impact factor: 3.396

6.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Identification of an arginine-rich motif in human papillomavirus type 1 E1;E4 protein necessary for E4-mediated inhibition of cellular DNA synthesis in vitro and in cells.

Authors:  Sally Roberts; Sarah R Kingsbury; Kai Stoeber; Gillian L Knight; Phillip H Gallimore; Gareth H Williams
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

8.  Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Authors:  Emma L Prescott; Claire L Brimacombe; Margaret Hartley; Ian Bell; Sheila Graham; Sally Roberts
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

9.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

10.  Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway.

Authors:  Isabelle Ote; Marielle Lebrun; Patricia Vandevenne; Sébastien Bontems; Cahora Medina-Palazon; Evelyne Manet; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.